The evidence is now clear: living with overweight or obesity increases the risk of multiple cancers, including bowel, endometrial, post-menopausal breast, kidney, liver, pancreatic, gallbladder, ovarian, gastric cardia, oesophageal adenocarcinoma, thyroid, meningioma, and multiple myeloma
PlexusDx Precision Peptide Genetic Testing identifies your genetic predispositions for GLP-1 response, enabling personalized dosing strategies that minimize nausea while optimizing results
Scientific Complexity in Early Development The pharmacological success of GLP-1 is underpinned by their pleiotropic effects on insulin secretion, appetite regulation, and gastric emptying
Time course of endocrine changes in the hypophysis-gonad axis induced by hypobaric hypoxia in male rats